Bourgeon Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $6.57M | Buy |
|
|||||
|
2024
Q2 | $5.36M | Sell |
|
|||||
|
2024
Q1 | $5.73M | Buy |
|
|||||
|
2023
Q4 | $6.22M | Sell |
|
|||||
|
2023
Q3 | $11.1M | Sell |
|
|||||
|
2023
Q2 | $11.4M | Sell |
|
|||||
|
2023
Q1 | $12.4M | Sell |
|
|||||
|
2022
Q4 | $12.9M | Sell |
|
|||||
|
2022
Q3 | $10.8M | Buy |
|
|||||
|
2022
Q2 | $10.7M | Buy |
|
|||||
|
2022
Q1 | $10.1M | Buy |
|
|||||
|
2021
Q4 | $12M | Buy |
|
|||||
|
2021
Q3 | $11.4M | Sell |
|
|||||
|
2021
Q2 | $11.3M | Buy |
|
|||||
|
2021
Q1 | $10.3M | Buy |
|
|||||
|
2020
Q4 | $5.99M | Sell |
|
|||||
|
2020
Q3 | $9.01M | Buy |
|
|||||
|
2020
Q2 | $6.34M | Buy |
|
|||||
|
2020
Q1 | $4.53M | Buy |
|
|||||
|
2019
Q4 | $250K | Sell |
|
|||||
|
2019
Q3 | $257K | Buy |
|
|||||
|
2019
Q2 | $226K | Hold |
|
|||||
|
2019
Q1 | $218K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $230K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $597K | Buy |
|
|||||
|
2016
Q2 | $576K | Buy |
|
|||||
|
2016
Q1 | $230K | Hold |
|
|||||
|
2015
Q4 | $253K | Hold |
|
|||||
|
2015
Q3 | $245K | Hold |
|
|||||
|
2015
Q2 | $293K | Hold |
|
|||||
|
2015
Q1 | $245K | Hold |
|
|||||
|
2014
Q4 | $236K | Hold |
|
|||||
|
2014
Q3 | $266K | Hold |
|
|||||
|
2014
Q2 | $207K | Buy |
|